Company profile for Pyxis Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pyxis Oncology has assembled a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to further improve the outcome for patients with cancer. Charting a course to therapeutics for difficult-to-treat cancer. Pyxis is advancing a diverse portfolio of immunotherapies that target broad immune regulatory mechanisms as well as novel im...
Pyxis Oncology has assembled a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to further improve the outcome for patients with cancer. Charting a course to therapeutics for difficult-to-treat cancer. Pyxis is advancing a diverse portfolio of immunotherapies that target broad immune regulatory mechanisms as well as novel immune checkpoints with the potential to transform the cancer treatment landscape.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
35 Cambridgepark Drive Cambridge
Telephone
Telephone
02140 (617) 221-9059
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/03/3179791/0/en/Pyxis-Oncology-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/13/3165794/0/en/Pyxis-Oncology-to-Present-Translational-Data-and-Key-Biology-Findings-Elucidating-the-Mechanism-of-Action-of-MICVO-at-Upcoming-Medical-Meetings.html

GLOBENEWSWIRE
13 Oct 2025

https://www.globenewswire.com/news-release/2025/10/09/3164040/0/en/Pyxis-Oncology-Appoints-Alex-Kane-as-Senior-Vice-President-Investor-Relations-Capital-Markets.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/09/30/3159076/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
30 Sep 2025

https://www.globenewswire.com/news-release/2025/08/21/3137025/0/en/Pyxis-Oncology-to-Participate-in-September-Investor-and-Industry-Conferences.html

GLOBENEWSWIRE
21 Aug 2025

https://www.globenewswire.com/news-release/2025/08/14/3133853/0/en/Pyxis-Oncology-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
14 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty